These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9249023)
1. Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK1 cells down-regulated for protein kinase C--correlation with cytoplasmic heterogeneous nuclear ribonucleoprotein C. Nanbu R; Montero L; D'Orazio D; Nagamine Y Eur J Biochem; 1997 Jul; 247(1):169-74. PubMed ID: 9249023 [TBL] [Abstract][Full Text] [Related]
2. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion. Montero L; Nagamine Y Cancer Res; 1999 Oct; 59(20):5286-93. PubMed ID: 10537311 [TBL] [Abstract][Full Text] [Related]
3. Multiple instability-regulating sites in the 3' untranslated region of the urokinase-type plasminogen activator mRNA. Nanbu R; Menoud PA; Nagamine Y Mol Cell Biol; 1994 Jul; 14(7):4920-8. PubMed ID: 8007988 [TBL] [Abstract][Full Text] [Related]
4. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells. Ziegler A; Knesel J; Fabbro D; Nagamine Y J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970 [TBL] [Abstract][Full Text] [Related]
5. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells. Han Q; Leng J; Bian D; Mahanivong C; Carpenter KA; Pan ZK; Han J; Huang S J Biol Chem; 2002 Dec; 277(50):48379-85. PubMed ID: 12377770 [TBL] [Abstract][Full Text] [Related]
6. Staurosporine stimulates expression of the urokinase-type (u-PA) plasminogen activator in LLC-PK1 cells. Dierks-Ventling C; Knesel J; Nagamine Y; Hemmings BA; Pehling G; Fischer F; Fabbro D Int J Cancer; 1989 Nov; 44(5):865-70. PubMed ID: 2583867 [TBL] [Abstract][Full Text] [Related]
7. A new genetic approach for studying hormonal regulation of urokinase-type plasminogen activator gene expression in LLC-PK1 cells. Hofstetter P; Kikinis Z; Altus MS; Pearson D; Nagamine Y Mol Cell Biol; 1987 Dec; 7(12):4535-41. PubMed ID: 2830499 [TBL] [Abstract][Full Text] [Related]
8. hsp70 mRNA accumulates in LLC-PK1 pig kidney cells treated with calcitonin but not with 8-bromo-cyclic AMP. Andrus L; Altus MS; Pearson D; Grattan M; Nagamine Y J Biol Chem; 1988 May; 263(13):6183-7. PubMed ID: 3360780 [TBL] [Abstract][Full Text] [Related]
9. Protein synthesis and urokinase mRNA metabolism. Shetty S Mol Cell Biochem; 2005 Mar; 271(1-2):13-22. PubMed ID: 15881651 [TBL] [Abstract][Full Text] [Related]
10. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Tran H; Maurer F; Nagamine Y Mol Cell Biol; 2003 Oct; 23(20):7177-88. PubMed ID: 14517288 [TBL] [Abstract][Full Text] [Related]
11. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression. Botteri FM; Ballmer-Hofer K; Rajput B; Nagamine Y J Biol Chem; 1990 Aug; 265(22):13327-34. PubMed ID: 1695907 [TBL] [Abstract][Full Text] [Related]
12. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C. Velusamy T; Shetty P; Bhandary YP; Liu MC; Shetty S Biochemistry; 2008 Jun; 47(24):6508-17. PubMed ID: 18494499 [TBL] [Abstract][Full Text] [Related]
13. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB. Sliva D; English D; Lyons D; Lloyd FP Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207 [TBL] [Abstract][Full Text] [Related]
14. Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism. Ziegler A; Hagmann J; Kiefer B; Nagamine Y J Biol Chem; 1990 Dec; 265(34):21194-201. PubMed ID: 1701176 [TBL] [Abstract][Full Text] [Related]
15. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator. Mahanivong C; Yu J; Huang S Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542 [TBL] [Abstract][Full Text] [Related]
16. Induction of uPA but not NF-IL3A by calcitonin is dependent on Erk1/2 phosphorylation in porcine renal cell line LLC-PK1. Nakamura M; Yang Q; Ozaki T; Nakamura Y; Yamasaki H; Mori I; Kakudo K Biochem Biophys Res Commun; 2002 Feb; 290(5):1483-8. PubMed ID: 11820789 [TBL] [Abstract][Full Text] [Related]
17. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. Guo Y; Pakneshan P; Gladu J; Slack A; Szyf M; Rabbani SA J Biol Chem; 2002 Nov; 277(44):41571-9. PubMed ID: 12198113 [TBL] [Abstract][Full Text] [Related]
18. Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene. Marksitzer R; Stief A; Menoud PA; Nagamine Y J Biol Chem; 1995 Sep; 270(37):21833-8. PubMed ID: 7665606 [TBL] [Abstract][Full Text] [Related]
19. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1. Najera I; Krieg M; Karn J J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777 [TBL] [Abstract][Full Text] [Related]